LifePlan Financial Group’s Boston Scientific BSX Stock Holding History

LifePlan Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$9K	Sell	237 -50	-17%	-$1.93K	﹤0.01%	413
2020 Q2	$10K	Sell	287 -25	-8%	-$900	﹤0.01%	406
2020 Q1	$10K	Sell	312 -43	-12%	-$1.68K	0.01%	396
2019 Q4	$16K	Hold	355	–	–	0.01%	370
2019 Q3	$14K	Hold	355	–	–	0.01%	384
2019 Q2	$15K	Hold	355	–	–	0.01%	366
2019 Q1	$14K	Hold	355	–	–	0.01%	375
2018 Q4	$13K	Hold	355	–	–	0.01%	364
2018 Q3	$14K	Hold	355	–	–	0.01%	359
2018 Q2	$12K	Hold	355	–	–	0.01%	363
2018 Q1	$10K	Buy	+355	New	+$9.65K	0.01%	360

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LifePlan Financial Group's BSX Position: Q3 2020 in Review

LifePlan Financial Group reduced its Boston Scientific (BSX) stake by 17% in Q3 2020, selling an estimated $1.93K and leaving 237 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

LifePlan Financial Group first reported a position in BSX in Q1 2018 and has held it in 11 quarters since. The position peaked at $16K in Q4 2019. 843 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

LifePlan Financial Group held 237 shares of Boston Scientific worth $9K as of Q3 2020.
LifePlan Financial Group sold 50 Boston Scientific shares in Q3 2020, an estimated $1.93K.
Boston Scientific made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #413 holding.
LifePlan Financial Group first reported a position in Boston Scientific in Q1 2018 and has held it in 11 quarters since.
LifePlan Financial Group's Boston Scientific position peaked at $16K in Q4 2019.
843 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.